Scientists have taken a major step toward developing an effective HIV vaccine after a new experimental vaccine successfully ...

Millions of HIV/AIDS patients, many of them in Africa, face an uncertain future as a financial cliff-edge for US-funded ...

As more people with HIV reach retirement age, the annual cost of antiretroviral therapy (ART) for Medicare for people 65 or ...

Researchers have developed a vaccine that has successfully generated "virus-fighting" antibodies in primates, which may help ...

Study findings show a considerable CMD burden among ART-naive PWH, highlighting the need to integrate prevention interventions into HIV care protocols..

Lack of political leadership and budget cuts are contributing factors, experts suggest ...

Around 44% of rhesus macaques vaccinated with the new HIV vaccine produced broadly neutralizing antibodies against HIV. The ...

After decades of failed HIV vaccines, a new approach that predicts which cells to train, not just what antigen to show, has ...

The incidence of skin diseases in people with HIV has declined significantly over the past decade, but some patient groups remain at a higher risk, particularly for cutaneous malignancies (CM), ...

A study evaluates whether people with HIV infection and solid organ transplant recipients have higher odds of HPV-related ...

A brief medical note in the U.S. CDC Morbidity and Mortality Weekly Report published 45 years ago would have profound impacts ...